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Abstract
Many parameters have been associated with sepsis prognosis. In
the present issue of Critical Care, Kumar and colleagues demon-
strate that a preserved cardiac answer to dobutamine evaluated by
radionucleotide measurements was associated with a better
prognosis during septic shock. In this context, it is interesting to
note that not only is the cardiac response to catecholamine stimu-
lation associated with prognosis, but also the vascular and meta-
bolic responses are associated. The ability of exogenous
catecholamine to increase the arterial pressure (dopamine test) or
to increase the lactate level is also related to prognosis. According
to the ubiquitous character of catecholamine sensitivity, therefore,
we should think in terms of cellular ability to respond to
catecholamines in defining the concept of physiological reserve.
In the present issue of Critical Care, Kumar and colleagues
[1] elegantly demonstrate using graded dobutamine chal-
lenge in septic shock patients combined with radionucleotide
measurement of cardiac function that only the survivors were
able to maintain cardiac responsiveness to dobutamine
stimulation. In fact, the prognosis value of a positive response
to dobutamine challenge has been already demonstrated in
several studies, in which the answer to dobutamine was
evaluated using different indices: the oxygen delivery/oxygen
consumption relationship in Vallet and colleagues’ study [2],
or an increase in the cardiac index in the studies of Rhodes
and colleagues [3] and of Jellema and colleagues [4].
It is interesting to note that not only is the cardiac response to
catecholamine stimulation associated with the prognosis, but
also the vascular and metabolic responses are associated.
For example, it is well demonstrated that hemodynamic
severity of septic shock is linked to the acuteness of
vasoplegia. In animal models and human studies, vasoplegia
is clearly related to hyporeactivity to exogenous and
endogenous vasopressors (norepinephrine and vasopressin,
for instance) [5]. Experimental and clinical data have
demonstrated that, between the many factors involved, an
overproduction of nitric oxide and peroxynitrite leading to the
stimulation of vascular potassium channels is responsible for
vascular hyporeactivity [6].
Despite this complicated pathophysiological network, it is
possible to simply assess vascular reactivity and thus the
septic shock prognosis using a dopamine test. We have
previously demonstrated that dopamine-sensitive patients –
for example, patients who were able to increase their mean
arterial pressure with a maximal dose of 20 μg/kg/min
dopamine – had a better prognosis (survival 78%) when com-
pared with dopamine-resistant patients (survival 16%) [7].
At the least, the metabolic response can be evaluated by the
ability to produce lactate. During septic shock, lactate
production may be related not only to a hypoxic mechanism
but also to an increased metabolic demand. Experimental
data have demonstrated that lactate production in the muscle
is linked to epinephrine stimulation of the Na+,K+-ATPase
pump. In human septic shock, we also demonstrated that
muscle was a net producer of lactate, and that this
production could be totally inhibited by ouabain, thus
confirming a Na+,K+-ATPase-dependent mechanism while
clearly independent of tissue hypoxia [8]. Muscle tissue,
which represents approximately 40% of the total body cell
mass, is particularly implicated in this mechanism, notwith-
standing that >99% of muscle adrenergic receptors are β2
receptors.
We recently demonstrated in low-flow (hemorrhagic) and
normal-to-high-flow models of shock (endotoxin and
peritonitis) that lactate production during shock states is
related, at least in part, to increased Na+,K+-ATPase activity
under  β2 stimulation [9]. Levraut and colleagues, using an
infusion of exogenous lactate to estimate lactate production
and clearance, found in stable normolactatemic septic shock
patients that survivors produced more lactate than
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nonsurvivors [10]. Similarly, the survivors were also better
able to clear this overproduction of lactate.
The response to catecholamine can therefore be studied at
the heart level using β1 stimulation, at the vessel level using α
stimulation, and at the metabolic level using β2 stimulation. It
remains unknown, however, whether this disturbed answer to
catecholamine response is due to a signaling problem at the
receptor or postreceptor levels or due to the tissue’s inability
to produce the physiological answer, or both.
To conclude, according to the ubiquitous character of
catecholamine sensitivity, we should think in terms of cellular
ability to respond to catecholamines in defining the concept
of physiological reserve rather than in terms of preload or
cardiac reserve.
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